Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hodgson

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactamsS J Macdonald, M D Dowle, L A Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysineR J Young, R M Beams, K Carter, et al.
Journal of Medicinal Chemistry|February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonistsPanayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Critical Care (London, England)|November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Bioorganic & Medicinal Chemistry|March 13, 2019
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitorsDavid N Deaton, Young Do, Jason Holt, et al.
American Journal of Respiratory and Critical Care Medicine|March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical IllnessCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Intracellular inhibition of human neutrophil elastase by orally active pyrrolidine-trans-lactamsS J Macdonald, M D Dowle, L A Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysineR J Young, R M Beams, K Carter, et al.
Journal of Medicinal Chemistry|February 16, 2013
Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonistsPanayiotis A Procopiou, John W Barrett, Nicholas P Barton, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitorsChristie A Schulte, David N Deaton, Elsie Diaz, et al.
Critical Care (London, England)|November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort studyCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Bioorganic & Medicinal Chemistry|March 13, 2019
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitorsDavid N Deaton, Young Do, Jason Holt, et al.
American Journal of Respiratory and Critical Care Medicine|March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical IllnessCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Pageof 12